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A missing vas
The vas deferens is seldom palpated during routine physical examination, though absence of the vas has important implications.
CASE HISTORY
A man of 45 with moderate obesity came for routine vasectomy under local anaesthesia after an initial outpatient consultation at which no physical examination had been performed. The right vas was successfully ligated; the surgeon then explored the other side but had to abandon the operation because of persistent patient discomfort and inability to ®nd the vas. At a second operation, performed under general anaesthesia, absence of the left vas was con®rmed. An ultrasound scan subsequently demonstrated absence of the ipsilateral kidney. COMMENT John Hunter ®rst described absence of the vas deferens in a cadaver in 1737 1 , and an association with ipsilateral renal agenesis has been noted 2,3 . The reported prevalence of unilateral absence of the vas deferens is between 0.06% and 0.8% 4,5 . Unilateral renal agenesis is less common, with an estimated prevalence of 0.1% 6 . However, of patients with unilateral absence of the vas deferens, up to 80% have ipsilateral renal agenesis 4 . Even when the kidney is present, it may be affected by a wide range of anomalies such as ectopia, malrotation, fusion and polycystic disease. Abnormalities in the solitary contralateral kidney occur in nearly 10% of such patients, ranging from ureteric obstruction to vesicoureteric re¯ux 4 . In addition, ipsilateral absence of the adrenal gland has been reported in 15±25% of patients with renal agenesis 7 .
Developmentally the Wolf®an duct, which ultimately forms the vas deferens, is derived from the mesonephric duct. The ureteric bud which likewise develops from the mesonephric duct forms the ureter, renal pelvis, calyces, and collecting tubules. Thus congenital absence of the Wolf®an duct precludes formation of a ureteric bud and results in renal agenesis. As in the case presented, the testicle is usually present in patients with a congenitally absent vas, since the testis is derived from the genital fold and not the mesonephric duct.
This case highlights the dif®culties which may result from a congenitally absent vas deferens during vasectomy, which is increasingly performed as a day-case ambulant procedure in family planning clinics. We recommend that, when the vas cannot be felt on one side, on clinical examination, the patient should undergo scrotal exploration under general anaesthesia, to allow a thorough search before the vas is declared congenitally absent. All such patients should have imaging of the renal tracts. Because of the association between congenital absence of the vas deferens and defects in the cystic ®brosis transmembrane conductance regulator gene, these patients should also undergo genetic cystic ®brosis screening 8 .
Absence of the vas deferens may be a useful warning sign in patients with blunt abdominal trauma requiring emergency surgery. Such patients should be assumed to have ipsilateral renal agenesis until proved otherwise. In the presence of infection (and its treatment), anticoagulant therapy can go dangerously out of control.
A woman aged 62 attended casualty because the vision in her only eye had suddenly deteriorated after a paroxysm of coughing. She gave a history of aortic and mitral valve replacements for rheumatic heart disease, and was taking warfarin with the aim of keeping the international normalized ratio (INR) between 2.5 and 3.5. A week before presentation she had begun a course of clarithromycin 250 mg twice daily for a chest infection. She had a complex ophthalmic history with bilateral cataract extraction in childhood and bilateral retinal detachment surgery at age 21. The left detachment repair had been successful with restoration of acuity to 6/18, but the right eye had become phthisical (blind and shrunken). On examination she was pyrexial with signs of a resolving chest infection. There was a left hyphaema in the anterior chamber. The fundus could not be examined because of vitreous opacity. Ocular ultrasonography revealed a dense vitreous and suprachoroidal haemorrhage (Figure 1) . Her INR was 8.2. Subsequent examination of the general practitioner's records showed an INR of 2.3 three days before clarithromycin and 2.9 three days into the course. The highest INR in the past four months had been 3.7.
The clarithromycin was stopped, the warfarin dose was adjusted and she was given 0.5 mg intravenous vitamin K. The chest infection cleared three days after admission. A vitrectomy with anterior chamber washout and partial drainage of the suprachoroidal haemorrhage was performed when her INR had fallen to 2.9. Unfortunately this did not improve her vision, which had now deteriorated to perception of light only.
COMMENT
A possible reason for the loss of anticoagulant control in this patient was the infection itself. However, we suspect that the cause was an interaction between clarithromycin and warfarin. This has been recorded in four previous case reports 1±3 . One described the interaction between clarithromycin, warfarin and digoxin in a woman with chronic atrial ®brillation 1 . Her INR at presentation was 7.3. She had gastrointestinal symptoms, weakness, dizziness and visual changes, but no permanent systemic or visual complications ensued. In the other three cases the INR rose to between 5.6 and >20 after taking clarithromycin and warfarin but no systemic symptoms developed 2,3 . Any of these patients could have suffered an intracerebral or other lifethreatening bleed with an elevated INR.
The most common ocular haemorrhagic complication of warfarin is subconjunctival haemorrhage; a rarer one is spontaneous hyphaema. These almost always resolve without 
